FAQ

flurpiridaz F18

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2011-2015
02420112015

Related topics

Related topics

1 relation

Broader (1)

BMS 747158-02

Related mentions per year

Related mentions per year

2009-2015
20002005201020152020
flurpiridaz F18
BMS 747158-02

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Dual-Gated Motion-Frozen Cardiac PET with Flurpiridaz F 18.
UNLABELLED A novel PET radiotracer, Flurpiridaz F 18, has undergone phase II clinical trial evaluation as a high-resolution PET… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2014
2014
Absolute quantitation of myocardial blood flow in human subjects with or without myocardial ischemia using dynamic flurpiridaz F 18 PET.
UNLABELLED Absolute quantitation of myocardial blood flow (MBF) by PET is an established method of analyzing coronary artery… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
Review
2014
Review
2014
Cardiac PET perfusion tracers: current status and future directions.
PET myocardial perfusion imaging (MPI) is increasingly being used for noninvasive detection and evaluation of coronary artery… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2013
2013
Phase II safety and clinical comparison with single-photon emission computed tomography myocardial perfusion imaging for detection of coronary artery disease: flurpiridaz F 18 positron emission…
OBJECTIVES This was a phase II trial to assess flurpiridaz F 18 for safety and compare its diagnostic performance for positron… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2012
2012
LMI1195 PET imaging in evaluation of regional cardiac sympathetic denervation and its potential role in antiarrhythmic drug treatment
Regional cardiac sympathetic denervation (RCSD) associated with reduced noradrenaline transporter (NAT) function has been linked… (More)
  • figure 1
  • figure 2
  • figure 4
  • figure 3
  • figure 5
Is this relevant?
Review
2012
Review
2012
Properties of an ideal PET perfusion tracer: new PET tracer cases and data.
An ideal positron emission tomography (PET) tracer should be highly extractable by the myocardium and able to provide high… (More)
  • figure 2
  • table 1
  • figure 1
  • figure 3
  • figure 4
Is this relevant?
2011
2011
Simplified quantification of myocardial flow reserve with flurpiridaz F 18: validation with microspheres in a pig model.
UNLABELLED The novel PET flow tracer flurpiridaz F 18 shows high myocardial extraction and slow washout. flurpiridaz F 18 PET… (More)
Is this relevant?
2011
2011
Automatic 3D registration of dynamic stress and rest (82)Rb and flurpiridaz F 18 myocardial perfusion PET data for patient motion detection and correction.
PURPOSE The authors aimed to develop an image-based registration scheme to detect and correct patient motion in stress and rest… (More)
  • figure 1
  • table I
  • table II
  • figure 2
  • figure 3
Is this relevant?
2011
2011
Evaluation of LMI1195, a novel 18F-labeled cardiac neuronal PET imaging agent, in cells and animal models.
BACKGROUND Heart failure has been associated with impaired cardiac sympathetic neuronal function. Cardiac imaging with… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2011
2011
Evaluation of LMI1195, a Novel F Labeled Cardiac Neuronal PET Imaging Agent, in Cells and Animal Models Yu et al: LMI1195 for Cardiac Neuronal PET Imaging
Background Heart failure (HF) has been associated with impaired cardiac sympathetic neuronal function. Cardiac imaging with… (More)
  • table 1
  • table 2
Is this relevant?